| COMPOSITION: | Each uncoated bilayered tablet contains Montelukast Sodium eq. to Montelukast 10 mg, Fexofenadine Hydrochloride 120 mg & Acebrophylline SR 200 mg |
| FORMULATION: | TABLETS |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Minolast-FXA tablet contains Montelukast, a Lukotriene inhibitor that relieves inflammation and oedema; Fexofenadine, an anti-allergic that relieves allergy & Acebrophylline in sustain release form which dilates airways of the respiratory tract and removes mucus from them. It is prescribed in cases of long standing asthma, respiratory tract congestion & allergic manifestations & other chronic lung diseases. |
| SIDE EFFECTS: | Main side effects are constipation, heart burn, loss of appetite, headache, drowsiness, dizziness, abdominal pain, dyspepsia & nausea. |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
